Khalid Al Balushi

Dr. Khalid Al Balushi

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
TCThe International Lung Cancer Consortium
The International Lung Cancer Consortium
MAMaría Soler Artigas
María Soler Artigas
GCGIANT consortium
GIANT consortium
DLDaan W Loth
Daan W Loth
LWLouise V Wain
Louise V Wain
MTMartin D Tobin
Martin D Tobin
Martin Tobin and colleagues report a meta-analysis of 23 genome-wide association studies for pulmonary function. They identify 16 loci newly associated with variation in two cross-sectional measures of lung function, used to define airway obstruction and to grade the severity of obstruction. Pulmonary function measures reflect respiratory health and are used in the diagnosis of chronic obstructive pulmonary disease. We tested genome-wide association with forced expiratory volume in 1 second and the ratio of forced expiratory volume in 1 second to forced vital capacity in 48,201 individuals of European ancestry with follow up of the top associations in up to an additional 46,411 individuals. We identified new regions showing association (combined P < 5 × 10−8) with pulmonary function in or near MFAP2, TGFB2, HDAC4, RARB, MECOM (also known as EVI1), SPATA9, ARMC2, NCR3, ZKSCAN3, CDC123, C10orf11, LRP1, CCDC38, MMP15, CFDP1 and KCNE2. Identification of these 16 new loci may provide insight into the molecular mechanisms regulating pulmonary function and into molecular targets for future therapy to alleviate reduced lung function.

9 September 2004 in Journal of Human Hypertension
Verified
Journal Article
Closed access
MTM O M Tanira
M O M Tanira
KBKhalid Al Balushi
Khalid Al Balushi

1 August 2006 in The Lancet
Verified
Journal Article
Closed access
IHIan P Hall
Ian P Hall
JBJohn D Blakey
John D Blakey
KBKhalid Al Balushi
Khalid Al Balushi
AWAmanda Wheatley
Amanda Wheatley
ISIan Sayers
Ian Sayers
DSDavid P Strachan
David P Strachan

4 June 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DMDhanalekshmi Unnikrishnan Meenakshi
Dhanalekshmi Unnikrishnan Meenakshi
GKGurpreet Kaur
Gurpreet Kaur
AAAlka Ahuja
Alka Ahuja
KBKhalid Al Balushi
Khalid Al Balushi
AFArul Prakash Francis
Arul Prakash Francis
SHAH ALAM KHANSHAH ALAM KHAN
SHAH ALAM KHAN
Natural compounds such as polyphenols play several positive roles in maintaining the oxidative and inflammatory capacity of cells, which leads to their potential use as anticancer therapeutics. There is promising evidence for the in vitro and in vivo anticancer activity of many polyphenols, including resveratrol and quercetin, specifically in the treatment of colorectal cancer (CRC). There is a clear association between resveratrol and quercetin in interfering with the mechanistic pathways involved in CRC, such as Wnt, P13K/AKT, caspase-3, MAPK, NF-κB, etc. These molecular pathways establish the role of resveratrol and quercetin in controlling cancer cell growth, inducing apoptosis, and inhibiting metastasis. The major bottleneck in the progression of the use of resveratrol and quercetin as anticancer therapeutics is their reduced bioavailability in vivo because of their rapid metabolism in humans. Recent advancements in various nanotechnological formulations are promising for overcoming these bioavailability issues. Various nanoformulations of resveratrol and quercetin have shown an optimistic impact on reducing the solubility and improving the stability of resveratrol and quercetin in vivo. A combinatorial approach using nanoformulations of resveratrol with quercetin could potentially increase the impact of resveratrol in controlling CRC cell proliferation. This review discusses the mechanism of resveratrol and quercetin, the two bioactive polyphenolics, in colon cancer, with an emphasis on various types of nanoformulations of the two molecules targeting colon cancer. It also explores the synergistic effect of combining resveratrol and quercetin in various nanoformulations, targeting colon cancer. This research delves into the enhanced pharmacokinetics and potential chemotherapeutic benefits of these bioactive polyphenolics when used together in innovative ways.

1 October 2014 in Primary Care Diabetes
Verified
Journal Article
Closed access
KBKhalid Al Balushi
Khalid Al Balushi
MAMahmod Al-Haddabi
Mahmod Al-Haddabi
IAIbrahim Al-Zakwani
Ibrahim Al-Zakwani
MZMohammed Al Za'abi
Mohammed Al Za'abi

21 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BABadreldin Ali
Badreldin Ali
SASuhail Al-Salam
Suhail Al-Salam
MZMohammed Al Za'Abi
Mohammed Al Za'Abi
KBKhalid Al Balushi
Khalid Al Balushi
ARAishwarya Ramkumar
Aishwarya Ramkumar
Abderrahim NemmarAbderrahim Nemmar
Abderrahim Nemmar
Different modes of exercise are reported to be beneficial in subjects with chronic kidney disease (CKD). Similar benefits have also been ascribed to the dietary supplement gum acacia (GA). Using several physiological, biochemical, immunological, and histopathological measurements, we assessed the effect of swimming exercise (SE) on adenine –induced CKD, and tested whether SE would influence the salutary action of GA in rats with CKD. Eight groups of rats were used, the first four of which were fed normal chow for 5 weeks, feed mixed with adenine (0.25% w/w) to induce CKD, GA in the drinking water (15% w/v), or were given adenine plus GA, as above. Another four groups were similarly treated, but were subjected to SE during the experimental period, while the first four groups remained sedentary. The pre-SE program lasted for four days (before the start of the experimental treatments), during which the rats were made to swim for 5 to 10 min, and then gradually extended to 20 min per day. Thereafter, the rats in the 5th, 6th, 7th, and 8th groups started to receive their respective treatments, and were subjected to SE three days a week for 45 min each. Adenine induced the typical signs of CKD as confirmed by histopathology, and the other measurements, and GA significantly ameliorated all these signs. SE did not affect the salutary action of GA on renal histology, but it partially improved some of the above biochemical and physiological analytes, suggesting that addition of this mode of exercise to GA supplementation may improve further the benefits of GA supplementation.